G. Paçacı Çetin Et Al. , "Biologics for the treatment of severe asthma: Current status report 2023," TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.71, no.2, pp.176-187, 2023
Paçacı Çetin, G. Et Al. 2023. Biologics for the treatment of severe asthma: Current status report 2023. TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.71, no.2 , 176-187.
Paçacı Çetin, G., Kepil Özdemir, S., Can Bostan, Ö., Öztop, N., Çelebi Sözener, Z., Karakaya, G., ... Gelincik Akkor, A.(2023). Biologics for the treatment of severe asthma: Current status report 2023. TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.71, no.2, 176-187.
Paçacı Çetin, Gülden Et Al. "Biologics for the treatment of severe asthma: Current status report 2023," TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.71, no.2, 176-187, 2023
Paçacı Çetin, Gülden P. Et Al. "Biologics for the treatment of severe asthma: Current status report 2023." TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.71, no.2, pp.176-187, 2023
Paçacı Çetin, G. Et Al. (2023) . "Biologics for the treatment of severe asthma: Current status report 2023." TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.71, no.2, pp.176-187.
@article{article, author={Gülden Paçacı Çetin Et Al. }, title={Biologics for the treatment of severe asthma: Current status report 2023}, journal={TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX}, year=2023, pages={176-187} }